More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

In patients who have a high likelihood of having lung cancer, there is little role for positron
emission tomography (PET) imaging for diagnosis of the primary lesion. The primary impact …

Lung cancer is a common disease and the leading cause of cancer-related mortality, with
non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following …

OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …

Especially for non-small cell lung cancer, FDG-PET has in the majority of the patients led to
the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and …

18F-FDG PET is the most accurate noninvasive modality for staging mediastinal lymph
nodes in lung cancer. Besides using visual image interpretation, some institutions use …

Objective: The impact of the (2-(fluorine-18)-fluoro-2-2deoxy-d-glucose)-positron emission
tomography (18F-FDG-PET) for discrimination of pulmonary lesions was evaluated in a …

PURPOSE: To prospectively study the impact of 18F fluorodeoxyglucose (FDG) positron
emission tomography (PET) on clinical management of patients with non–small-cell lung …

Carcinoma of the lung is one of the most frequent malignancies and a major cause of
mortality. The use of positron emission tomography (PET) has been extensively investigated …

Purpose The purpose of the study was to evaluate prospectively whether integrated 2-deoxy-
2-[18 F] fluoro-d-glucose positron emission tomography/computed tomography (FDG …